252 related articles for article (PubMed ID: 14625496)
1. Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma.
Shepler TR; Sherman SI; Faustina MM; Busaidy NL; Ahmadi MA; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2003 Nov; 19(6):479-81. PubMed ID: 14625496
[TBL] [Abstract][Full Text] [Related]
2. [Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma].
Fonseca FL; Lunardelli P; Matayoshi S
Arq Bras Oftalmol; 2012; 75(2):97-100. PubMed ID: 22760799
[TBL] [Abstract][Full Text] [Related]
3. Nasolacrimal drainage obstruction after radioiodine therapy: case report and a review of the literature.
Brockmann H; Wilhelm K; Joe A; Palmedo H; Biersack HJ
Clin Nucl Med; 2005 Aug; 30(8):543-5. PubMed ID: 16024949
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.
Savage MW; Sobel RK; Hoffman HT; Carter KD; Finkelstein MW; Shriver EM
Ophthalmic Plast Reconstr Surg; 2015; 31(3):e50-2. PubMed ID: 24836449
[TBL] [Abstract][Full Text] [Related]
5. Relationship between radioactive iodine therapy for thyroid carcinoma and nasolacrimal drainage system obstruction.
Cetinkaya A; Kersten RC
Ophthalmic Plast Reconstr Surg; 2007; 23(6):496. PubMed ID: 18030131
[No Abstract] [Full Text] [Related]
6. Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer.
Sakahara H; Yamashita S; Suzuki K; Imai M; Kosugi T
Ann Nucl Med; 2007 Nov; 21(9):525-7. PubMed ID: 18030585
[TBL] [Abstract][Full Text] [Related]
7. Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients.
Morgenstern KE; Vadysirisack DD; Zhang Z; Cahill KV; Foster JA; Burns JA; Kloos RT; Jhiang SM
Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):337-44. PubMed ID: 16234694
[TBL] [Abstract][Full Text] [Related]
8. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma.
Kloos RT; Duvuuri V; Jhiang SM; Cahill KV; Foster JA; Burns JA
J Clin Endocrinol Metab; 2002 Dec; 87(12):5817-20. PubMed ID: 12466391
[TBL] [Abstract][Full Text] [Related]
9. Nasolacrimal obstruction secondary to I(131) therapy.
Burns JA; Morgenstern KE; Cahill KV; Foster JA; Jhiang SM; Kloos RT
Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):126-9. PubMed ID: 15083081
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic dacryocystorhinostomy following radioactive iodine thyroid ablation.
Van Tassel SH; Segal KL; Hsu NM; Kacker A; Lelli GJ
Orbit; 2017 Apr; 36(2):59-63. PubMed ID: 28388347
[TBL] [Abstract][Full Text] [Related]
11. Epiphora after radioactive iodine ablation for thyroid cancer.
Sun GE; Hatipoglu B
Thyroid; 2013 Feb; 23(2):243-5. PubMed ID: 22946448
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of 131Iodine in the nasolacrimal sac/duct after radioiodine therapy for papillary thyroid cancer.
Usmani S; Jain A; Al-Riyami K; Abubakar S
J Pak Med Assoc; 2023 Mar; 73(3):713-714. PubMed ID: 36932793
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic endonasal retrieval of a nasolacrimal duct stone via the valve of Hasner in the inferior meatus.
Cnaan RB; Moosajee M; Heatley CJ; Olver JM
Ophthalmic Plast Reconstr Surg; 2012; 28(2):e48-50. PubMed ID: 21743370
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic study of lacrimal sac and nasal mucosa in 44 patients with complete acquired nasolacrimal duct obstruction.
Mauriello JA; Palydowycz S; DeLuca J
Ophthalmic Plast Reconstr Surg; 1992; 8(1):13-21. PubMed ID: 1554647
[TBL] [Abstract][Full Text] [Related]
15. Lacrimal System Obstruction After Radioiodine Therapy in Differentiated Thyroid Carcinomas: A Prospective Comparative Study.
da Fonseca FL; Yamanaka PK; Kato JM; Matayoshi S
Thyroid; 2016 Dec; 26(12):1761-1767. PubMed ID: 27565021
[TBL] [Abstract][Full Text] [Related]
16. Primary Nasolacrimal Duct Obstruction Visualized on
Kay MD; Morris-Wiseman LF; Beazer A; Winegar BA; Kuo PH
J Nucl Med Technol; 2020 Mar; 48(1):77-78. PubMed ID: 31604890
[TBL] [Abstract][Full Text] [Related]
17. Nasolacrimal duct obstruction caused by an oncocytoma.
de Bree R; Scheeren RA; Kummer A; Tiwari RM
Rhinology; 2002 Sep; 40(3):165-7. PubMed ID: 12357720
[TBL] [Abstract][Full Text] [Related]
18. Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
Yartsev VD; Atkova EL; Ekaterinchev MA
Int Ophthalmol; 2023 Sep; 43(9):3385-3390. PubMed ID: 37199817
[TBL] [Abstract][Full Text] [Related]
19. Nasolacrimal duct obstruction secondary to lacrimal sac involvement by sebaceous carcinoma.
Wu A; Curragh DS; Morrow R; Selva D; Davis G
Orbit; 2020 Dec; 39(6):433-436. PubMed ID: 31809621
[TBL] [Abstract][Full Text] [Related]
20. Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases.
Makselis A; Petroska D; Kadziauskiene A; Jaruseviciene R; Ruzgys A; Cimbalas A; Besusparis J; Asoklis RS
BMC Ophthalmol; 2022 Jan; 22(1):12. PubMed ID: 34986808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]